Is Angi, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. Based on the current metrics, Angi appears to be fairly valued. The P/E ratio stands at 16, while the EV to EBITDA ratio is 8.45, and the Price to Book Value is 0.81. These ratios suggest that the company is positioned reasonably within its industry.
In comparison to peers, Angi, Inc. has a P/E ratio of 14.77, which is lower than GoodRx Holdings, Inc. at 31.76, indicating that Angi may be undervalued relative to this competitor. Additionally, eGain Corp., which is rated attractive, has a significantly lower EV to EBITDA ratio of 23.15, further highlighting Angi's competitive positioning. Although return data is not available, the stock's performance relative to the S&P 500 could provide further context to its valuation narrative.